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Abstract
Background: Ultra Conserved Regions (UCRs) are a class of 481 noncoding sequences located in both intra- and
inter-genic regions of the genome. The recent findings that they are significantly altered in adult chronic
lymphocytic leukemias, carcinomas, and pediatric neuroblastomas lead to the hypothesis that UCRs may play a role
in tumorigenesis.
Results: We present a novel application of Ribo-SPIA™ isothermal linear amplification of minute RNA quantities for
quantifying Transcribed-UCR (T-UCR) expression by quantitative PCR. Direct comparison of non-amplified with
amplified cDNA in two neuroblastoma cell lines showed that the amplification approach increases sensitivity and
repeatability in T-UCR quantification. It is noteworthy that the Ribo-SPIA™ step allowed us to analyze all 481 T-UCRs
by using 150 ng of RNA, while introducing a minimal bias and preserving the magnitude of relative expression.
Only the less abundant T-UCRs have high intra-assay variability, consistently with the Poisson distribution statistics
and stochastic effects on PCR repeatability.
Conclusions: We demonstrated that the quantification procedure shown here is an accurate and reliable
technique for genome-wide non coding gene (i.e., UCRs) profiling using small amounts of RNA. This issue is
particularly important because studies of transcription regulation are increasingly conducted in small homogeneous
samples, such as laser capture microdissected or sorted cell populations.
Background
Ultra Conserved Regions (UCRs) are a class of noncod-
ing sequences discovered in 2004 by Bejerano and col-
leagues [1,2]. The UCRs are located in both intra- and
inter-genic regions and 53% of them are nonexonic,
whereas the remaining 47% are either overlapping
m R N A so rp o s s i b l ye x o n i c .S i n c eU C R sr e p r e s e n ta
group of 481 sequences (200-779 bp in length) that are
100% conserved among orthologous regions of human,
mouse, and rat genomes, it has been suggested they may
be involved in ontogeny and phylogeny of mammals and
other vertebrates [3]. Previous studies identified a func-
tional role for these noncoding sequences both in regu-
lation of alternative splicing and in promoting the
expression of several genes [3]. Calin et al. [4] demon-
strated that UCRs are significantly altered at both geno-
mic and expression levels in adult chronic lymphocytic
leukemias, colorectal and hepatocellular carcinomas. We
recently profiled both T-UCRs and microRNAs in a
cohort of 34 high-risk neuroblastoma (NB) tumors, with
the aim to investigate their putative role as sensitive
markers of outcome prediction in children with stage 4
NB [5]. Our study identified for the first time a signa-
ture based on T-UCR expression that is associated with
good outcome in non infant patients diagnosed with
metastatic NB. Moreover, our findings strongly suggest
that a deregulation of the microRNA/T-UCR network
may play an important role in the pathogenesis of
neuroblastoma.
Microarrays, Northern blot and reverse transcription-
quantitative real-time PCR (RT-qPCR) have been suc-
cessfully used to detect T-UCR expression [4]. However,
these methods preclude the use of many samples of
potential clinical interest, such as tumor biopsies, laser
microdissected tissues, and sorted cell populations,
because of the high quantities of RNA required for
expression analysis of all 481 T-UCRs. On this account,
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from low-input RNA is an emerging challenge in mole-
cular biology.
Ribo-SPIA™ technology [6], developed by NuGEN™
Technologies, enables a fast, simple and sensitive
method for preparing amplified cDNA from total RNA
to detect low, medium, and high abundance transcripts.
The amplified product is single-stranded cDNA in the
antisense direction of the st a r t i n gR N Aa n di ti sr e a d y
for qPCR without any purification. Such RNA amplifica-
tion procedure is suitable for expression analysis of both
eukaryotic and prokaryotic genes [7,8]. For the first time
here we present a novel application of the Ribo-SPIA™
isothermal linear amplification of minute RNA quanti-
ties for quantifying non-coding protein gene expression.
Methods
Cell lines and RNA isolation
Two NB cell lines (LAN-5 and GI-ME-N) (provided by
Interlab Cell Line Collection (ICLC), http://www.iclc.it)
were cultured at 37°C and 5% CO2 in RPMI 1640 medium
(Lonza, Basel, Switzerland), supplemented with 2 mM L-
glutamine, 1% non-essential amino acids, and 10% foetal
bovine serum. Total RNA was extracted by using the Per-
fectPure™ RNA Cell Kit (5Prime, Hamburg, Germany),
including on-column RNase-free DNase I treatment
(Ambion, TX, USA). Total and small RNAs were quanti-
fied and quality control was assessed by RNA 6000 Nano®
and Small RNA® assays, respectively, on the 2100 Bioanaly-
zer (Agilent Technologies, Santa Clara, CA). RNA samples
showed a RNA integrity number = 9.2. Both RNA samples
have been validated as DNA-free by a no-reverse tran-
scription assay for Eukaryotic 18S rRNA gene.
Reverse transcription of total RNA
RNA (1 μg) was reverse transcribed using 20 pmoles of
random hexamers (Eppendorf, Hamburg, Germany) and
200 U of SuperScript II enzyme (Invitrogen Life Tech-
nologies, Carlsbad, CA) in a total reaction volume of 20
μl. The mixture was incubated in a Mastercycler® epGra-
dient S (Eppendorf) at 25°C for 10 minutes, 42°C for 60
minutes, and 85°C for 5 minutes to stop the reaction.
cDNA was diluted 10-fold in molecular biology grade
water to a final concentration of 5 ng/ul, assuming
100% reverse transcription efficiency.
Reverse transcription and amplification of total RNA
RNA was reverse transcribed and amplified by the WT-
Ovation™ RNA Amplification System kit (NuGEN Tech-
nologies, San Carlos, CA) following manufacture’s
protocol and using the Mastercycler® epGradient S
(Eppendorf). In each reaction RNA input was 50 ng and
cDNA product was diluted 1:25 in molecular biology
grade water.
Quantification of T-UCRs by qPCR
T-UCRs were quantified by pre-optimized Transcribed
Ultra Conserved Regions real-time PCR assays (Primer-
Design Ltd, Hants, UK) using SYBR® green chemistry.
Each assay was individually validated by PrimerDesign
Ltd and shown to be 100% specific and close to 100%
efficient. The qPCR reactions were carried out in a total
volume of 10 μl, containing 2 μl of diluted cDNA, 2.5×
RealMaster Mix SYBR ROX (5Prime) and 150 nM of
the specific T-UCR primer mix. Quantification of 18S
rRNA, used as reference gene, was performed by using
VIC-labeled TaqMan® Gene Expression assay (Applied
Biosystems, Foster City, CA) in a total volume of 10 μl,
containing 2 μl of diluted cDNA, 2.5× RealMaster Mix
Probe (5Prime) and 20× primer/probe mix. Reactions
were setup in 96-white-well Twin.tec® real-time plates
(Eppendorf) by means of EpMotion 5070 Liquid Hand-
ling Workstation (Eppendorf). All reactions were per-
formed in duplicate on the Mastercycler® epRealPlex
4 S
system (Eppendorf). Cycling conditions were as follows:
95°C for 2 minutes, 40 cycles at 95°C for 15 seconds
and at 60°C for 1 minutes, followed by a melting curve
(ramping from 60°C to 95°C in 20 minutes) to ensure
the presence of the specific amplicon. Specificity of
qPCR reactions has been assessed by melting curve ana-
lysis and single runs were excluded when the melting
curves revealed unintended amplification products (e.g.,
primer dimers): curves with more than one peak, or one
single peak but with a melting temperature different
from the expected one (calculated by PrimerDesign’s
design software, accounting salt conditions of the mas-
termix). Raw qPCR data, melting temperatures and a
checklist according to the Minimum Information for
Publication of Quantitative Real-Time PCR Experiments
(MIQE) [9,10] are submitted as Supplemental data (see
additional file 1: Raw Cq data; additional file 2: Tm
data; additional file 3: MIQE checklist).
Data analysis
RealPlex software v. 2.0 (Eppendorf) was used to deter-
mine quantification cycle (Cq) in non-amplified (CqNA)
and amplified (CqA) total RNA samples. For each cDNA,
the duplicate T-UCR Cq values were averaged, and the
normalized Cq (dCq) was calculated by subtracting the
mean Cq value for 18S rRNA from each T-UCR mean
Cq value. Potential bias introduced upon the cDNA
amplification step and reliability of differential T-UCR
expression were assessed as previously described by
Mestdagh et al. [11]. Briefly, differential T-UCR expres-
sion between LAN-5 and GI-ME-N cell lines (ΔCq =
dCqGI-ME-N -d C q LAN-5) was determined for each
method, with (ΔCqA)o rw i t h o u t( ΔCqNA) amplification.
Then, we have calculated the difference in differential
T-UCR expression (ΔΔCq = ΔCqA - ΔCqNA). Optimal
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amplification should result in a difference lower than 1
PCR cycle (|ΔΔCq| < 1). The MedCalc® software (Maria-
kerke, Belgium) was used for statistical analyses. Signifi-
cance tests were two tailed.
Results
Amplification approach increases sensitivity in
T-UCR quantification
In this study we analyzed expression of 481 UCRs in
LAN-5 and GI-ME-N cell lines by RT-qPCR either with
or without cDNA amplification. Since it is known that a
single copy target is generally detected around cycle 35,
t h o s eT - U C R ss h o w i n gaC q NA above 35 were consid-
ered as not expressed. In qPCR assays performed on
non-amplified GI-ME-N and LAN-5 cDNAs the quanti-
fication rates were 384 and 357 T-UCRs, respectively,
whereas upon amplification the quantification rate
increased on average of 12% (up to 438 and 423
T-UCRs in GI-ME-N and LAN-5, respectively). The
results above demonstrate the improvement of informa-
tive data interrogation by RT-qPCR of the amplified
samples as compared to those generated using reverse
transcription of total RNA. It is noteworthy that the
qPCR reaction inputs were equivalent between amplified
and non-amplified samples. In fact, assuming 100%
amplification efficiency according to the WT-Ovation™
technical reports http://www.nugeninc.com, amplifica-
tion of 50 ng total RNA should result in about 4 μgo f
cDNA. The cDNA in 40 μl was diluted 1:25, then 2 μl
(approximately cDNA equivalents of 8 ng) were added
per qPCR run. Similarly, cDNA equivalents of 10 ng
were used for non-amplified cDNA.
Amplification approach increases repeatability in
T-UCR quantification
We validated qPCR results by measuring intra-assay var-
iation. We performed duplicate qPCR runs and rough
Cq values were used to calculate the standard deviation
(SD) for the Cq variance of each T-UCR. Highly and
moderately expressed T-UCRs (CqNA ≤ 30) have low SD
in both non-amplified (average SD = 0.16) and amplified
(average SD = 0.09) LAN-5 templates (Figure 1). The
SD values increase for low expressed T-UCRs (30 <
CqNA ≤ 35), for both amplified and non-amplified
cDNA, showing a relevant PCR variability only at the
lowest abundant ranges. Similar results were obtained in
GI-ME-N cell line (see additional file 4: Figure S1). In
LAN-5 cells, the number of assessable duplicated
T-UCR runs with a SD ≤ 1 significantly increases upon
the amplification process (378 out of 398 in non-ampli-
fied cDNA versus 372 out of 373 in amplified cDNA,
Figure 1 Plots showing the relation between the average Cq value and the standard deviation for T-UCRs in LAN-5 cell line, using
reverse transcriptase of total RNA (A) and amplification system (B). Bar plots display the mean SD value for T-UCRs with an average Cq
value ranging between 15-20, >20-25, >25-30, and >30-35 cycles.
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T-UCRs show a SD ≤ 1 in non-amplified GI-ME-N
cDNA compared to 358 out of 359 T-UCRs in amplified
cDNA (p = 0.006, Fisher’s exact test).
Minimal bias due to the amplification approach
In order to assess the potential bias introduced upon the
amplification step in each NB cell line, normalized Cq
values obtained with the WT-Ovation™ system (dCqA)
were compared with those obtained by reverse tran-
scriptase of total RNA (dCqNA). Scatter plots for both
LAN-5 and GI-ME-N samples (Figure 2) show a linear
correlation between normalized Cq with or without
amplification with correlation coefficient r ≅ 0.88,
indicating that the amplification approach provides a
reliable representation of T-UCR transcript abundance
in non-amplified cDNA. In order to evaluate why data
sets do not perfectly fit with a straight line correlation
model, we divided T-UCRs into three groups: highly
(CqNA ≤ 25), moderately (25 < CqNA ≤ 30), and low
expressed (30 < CqNA ≤ 35) T-UCRs. Upon amplifica-
tion step in LAN-5 cell line, linear correlation analysis
shows high biases for the low abundant T-UCRs (r =
0.2696) as compared to the moderately (r = 0.7494) and
highly (r = 0.8880) expressed T-UCRs. Similar results
were obtained in GI-ME-N cell line: r = 0.4508, 0.7259,
and 0.9056 for low, moderately and highly expressed
T-UCRs, respectively.
Figure 2 Scatter plots showing the linear correlation (r) between normalized Cq values obtained with the SPIA™ system (dCqA) and by
reverse transcriptase of total RNA (dCqNA) in LAN-5 (A) and GI-ME-N (B) cell lines.
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T-UCR expression
We wondered whether upon amplification step the level
of T-UCR expression was maintained. For this purpose,
we calculated the difference between LAN-5 and GI-
ME-N in T-UCR expression measured both with and
without amplification. The plot of the differential
T-UCR expression against each dCqNA value shows that
65% of the detectable T-UCRs display a |ΔΔCq| ≤ 1
(Figure 3). Moreover, our results show a near-perfect
correlation in differential T-UCR expression (|ΔΔCq| =
0.4) for the most abundant T-UCRs, whereas the aver-
age |ΔΔCq| value increases for the moderately expressed
T-UCRs (average |ΔΔCq| = 0.9), and further for the low
expressed T-UCRs (average |ΔΔCq| = 3.6). Consistently,
by setting the CqNA cutoff at 30, 81% of the detectable
T-UCRs display a |ΔΔCq| ≤ 1.
Discussion
In this study, we evaluated the sensitivity, repeatability,
and reliability of a cDNA amplification procedure for
estimating T-UCR expression by RT-qPCR. This
approach comprises steps for cDNA synthesis followed
by SPIA™-based linear, isothermal amplification initiated
both at the 3’ end and randomly throughout the whole
transcriptome [6]. Quantification of the corresponding
single-stranded cDNA product is based on the SYBR®
Green intercalating chemistry. We directly compared
non-amplified with amplified cDNAs of LAN-5 and GI-
ME-N neuroblastoma cell lines. It is noteworthy that we
Figure 3 Plot of the difference in differential T-UCR expression between LAN-5 and GI-ME-N cell lines against each mean dCqNA value.
Bar plot shows the mean |ΔΔCq| value for T-UCRs with an average CqNA value ranging between 15-20, >20-25, >25-30, and >30-35 cycles.
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tion approach by using equivalent cDNA inputs (10 ng)
for each amplified and non-amplified sample. The
superior sensitivity of a total RNA amplification prior to
qPCR is demonstrated, in fact about 12% more T-UCRs
were reliably and reproducibly quantified by the SPIA™
system than using reverse transcriptase of total RNA,
independently of the cell line.
Three separate RNA reverse transcriptions and three
amplification reactions were performed per sample to
interrogate all 481 T-UCRs. Therefore, to minimize the
bias in RNA processing efficiency, we separately pooled
non-amplified and amplified cDNAs necessary for all
subsequent qPCR runs. However, we measured intra-
assay variation due to i.e. robotic liquid handling and
PCR equipments by calculating the amount of error
when T-UCR assays were performed in duplicate. Stan-
dard deviation values showed an high repeatability of
sample replicates for highly and moderately expressed T-
UCRs, independently of the quantification method, indi-
cating the unbiased amplification procedure. Only the
lowest abundant T-UCRs have high intra-assay variabil-
ity, consistently with the influence of Poisson distribution
statistics and stochastic effects on PCR repeatability [12].
The major risk of an amplification procedure is the
loss of the proportional representation of T-UCR
expression levels in biological samples. Previous studies
reported the successful use of the SPIA™-basedprocedure
in expression profiling of both eukaryotic and prokaryo-
tic genes [6], but so far the effects of such linear amplifi-
cation on non-coding protein genes have not been
evaluated. We therefore assessed the potential bias of
the WT-Ovation™ system by comparison of T-UCR
expression in LAN-5 and GI-ME-N cell lines with or
without cDNA amplification. Correlation coefficient
values showed a very good linear relationship among
paired amplified and non-amplified samples for highly
and moderately expressed T-UCRs. The SPIA™ system
thus provides a reliable representation of the most
abundant T-UCR transcripts. Variation was high only
for rare T-UCRs, that displayed considerable amplifica-
tion bias affecting their differential expression. Our
results are consistent with the influence of stochastic
models, which significantly contribute to evaluate the
accuracy of transcript quantification at low levels [13].
In particular, the Poisson’s statistics predict the fre-
quency distribution of the number of RNA molecules
that will be present for measurement in each PCR tube.
In this context, stochastic fluctuations influence the sen-
sitivity when only a small amount of quantifiable tran-
scripts is available. This implies that the number of
measurement repetitions is relevant in the quantification
of rare transcripts and that repeated measurements of a
transcript at low level should exactly reflect the Poisson
type of distribution. For example, with two replicates
(which is the number of qPCR runs that we conducted
per T-UCR) there is 86.5% chance to detect at least one
positive score when the expected value is 1. Under the
Poisson assumption, 8 replicates would detect the
remaining 13.5% [14]. However, it is questionable that
this improvement in accuracy is worth the cost. As a
practical matter, it should be unrealistic to perform all
necessary replicate assays to determine the exact
amount of rare T-UCR transcripts, also taking into
account that our analysis revealed that the trend of dif-
ferential expression is always preserved for the low
abundant T-UCRs.
It is noteworthy that the amplification approach
allowed us to significantly reduce the amount of RNA
(150 ng) required to analyze all 481 T-UCRs per each
sample, preserving in the meantime the magnitude of
relative expression. Therefore, the quantification proce-
dure described here is both an accurate and reliable
technique for genome-wide T-UCR profiling when mini-
mal amounts of starting material are available. This
requirement is particularly important because tumor
sample size is often limited and studies of transcription
regulation are increasingly conducted in small homoge-
neous samples, such as laser capture microdissected or
sorted cell populations. It is noteworthy that the biologi-
cal implications of the scientific advance presented in
this manuscript have been recently published [5]. In
fact, we applied the linear isothermal Ribo-SPIA™ ampli-
fication method on 34 NB biopsies and this enabled us
to establish a T-UCR-expression signature predictive of
outcome in non infant patients diagnosed with meta-
static NB.
Conclusions
We have demonstrated that the SPIA™ system global
amplification of minute amounts of RNA prior to qPCR
enables sensitive and accurate interrogation of all 481
T-UCRs, while expression data should be considered
with caution for rare T-UCRs only. We strongly believe
that our results open the way to use the method pre-
sented here for an accurate high-throughput profiling of
non coding protein genes in those samples of potential
clinical interest, such as tumor biopsies, laser microdis-
sected tissues, and sorted cell populations, when limited
RNA amounts are available.
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Information for Publication of Quantitative Real-Time PCR Experiments.
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Additional file 4: Figure S1. Plots showing the correlation between the
average Cq value and the standard deviation for T-UCRs in GI-ME-N cell
line, using reverse transcriptase of total RNA (A) and amplification system
(B). Bar plots display the mean SD value for T-UCRs with an average Cq
value ranging between 15-20, >20-25, >25-30, and >30-35 cycles.
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